Summit Rock Advisors LP's Q3 2022 13F: 1 new position, 4 exits
Form 13F-HR for the quarter ended Sep 30, 2022 · filed Nov 2, 2022 · 5 reported positions · accession 0001172661-22-002275
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Increased | SELECT SECTOR SPDR TR (XLE) | 49.3% | 61.0% | +11.7 pts | +241K sh | +29% |
| Reduced | ISHARES TR (IWN) | 46.7% | 34.1% | −12.6 pts | −81,138 sh | −19% |
| Increased | VANGUARD INTL EQUITY INDEX F (VT) | 2.2% | 4.1% | +1.9 pts | +35,271 sh | +113% |
| Exited | ADVANCED DRAIN SYS INC DEL (WMS) | 0.5% | — | −0.5 pts | −7,448 sh | −100% |
| New | PLANET LABS PBC (PL) | — | 0.4% | +0.4 pts | +103K sh | new |
| Exited | CLOVER HEALTH INVESTMENTS CO (CLOV) | 0.4% | — | −0.4 pts | −211K sh | −100% |
| Exited | PHATHOM PHARMACEUTICALS INC (PHAT) | 0.2% | — | −0.2 pts | −34,100 sh | −100% |
| Exited | DYNE THERAPEUTICS INC (DYN) | 0.2% | — | −0.2 pts | −34,887 sh | −100% |
| Reduced | DAY ONE BIOPHARMACEUTICALS I (DAWN) | 0.5% | 0.4% | −0.1 pts | −7,374 sh | −22% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 100.0% of the equity book
Changes in the top 10 this quarter: PL entered · WMS left · CLOV left · PHAT left · DYN left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | SELECT SECTOR SPDR TR (XLE) | 49.3% | 61.0% | |
| 2 | ISHARES TR (IWN) | 46.7% | 34.1% | |
| 3 | VANGUARD INTL EQUITY INDEX F (VT) | 2.2% | 4.1% | |
| 4 | PLANET LABS PBC (PL) | 0.0% | 0.4% | Entered the top 10 |
| 5 | DAY ONE BIOPHARMACEUTICALS I (DAWN) | 0.5% | 0.4% | |
| — | ADVANCED DRAIN SYS INC DEL (WMS) | 0.5% | 0.0% | Left the top 10 |
| — | CLOVER HEALTH INVESTMENTS CO (CLOV) | 0.4% | 0.0% | Left the top 10 |
| — | PHATHOM PHARMACEUTICALS INC (PHAT) | 0.2% | 0.0% | Left the top 10 |
| — | DYNE THERAPEUTICS INC (DYN) | 0.2% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).